Per Flodgren (Former)
1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer : Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial
(
- Contribution to journal › Article
- 2009
-
Mark
Tyrosine kinase inhibition in renal cell carcinoma and gastrointestinal stromal tumours: case reports
2009) Symposium on Expanding the Boundaries of Clinical Practice - Building an Experience with Targeted Therapies 20. p.25-31(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Optimal management of metastatic renal cell carcinoma: an algorithm for treatment.
(
- Contribution to journal › Article
-
Mark
Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma.
(
- Contribution to journal › Article
- 2004
-
Mark
Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study.
(
- Contribution to journal › Article
- 2003
-
Mark
A systematic overview of radiation therapy effects in urinary bladder cancer
(
- Contribution to journal › Article
- 1996
-
Mark
Risk of cancer in relatives of testicular cancer patients
(
- Contribution to journal › Article
-
Mark
Familial testicular cancer in Norway and southern Sweden
(
- Contribution to journal › Article
- 1985
-
Mark
Immune functions in melanoma patients during treatment with interferon [HuIFN-alpha (Le)] alone or in combination with cimetidine
(
- Contribution to journal › Article
- 1984
-
Mark
Complete remission in a patient with acute myelogenous leukemia treated with leukocyte α-interferon and cimetidine
(
- Contribution to journal › Article